Article(id=1330225315651105786, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225302346773381, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2022.04.002, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1643040000000, receivedDateStr=2022-01-25, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795080029642, onlineDateStr=2026-11-19, pubDate=1649520000000, pubDateStr=2022-04-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795080029642, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795080029642, creator=13701087609, updateTime=1795080029642, updator=13701087609, issue=Issue{id=1330225302346773381, tenantId=1146029695717560320, journalId=1319690329412173987, year='2022', volume='43', issue='4', pageStart='347', pageEnd='484', issueExtLink='null', onlineDate='null', pubDate='1649520000000', pubDateStr='2022-04-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795080026470, creator='13701087609', updateTime=1795084707533, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330244936621994666, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225302346773381, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330244936621994667, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225302346773381, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=352, endPage=358, ext={EN=ArticleExt(id=1330225315869209595, articleId=1330225315651105786, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Analysis on the dilemma of medical insurance access for chimeric antigen receptor T cell products, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

As a novel cancer immunotherapy, chimeric antigen receptor T cell (CAR-T) therapy has good clinical efficacy but high treatment cost. Many foreign countries have included CAR-T in the medical insurance coverage to improve its affordability, however, CAR-T has not been included in National Reimbursement Drug List (NRDL) in China. By sorting the global CAR-T treatment status and medical insurance access situation, the paper summarized three difficulties for CAR-T access to NRDL, and proposed a three-stage solution of “independent payment of commercial health insurance-cooperative payment of commercial health insurance-regular payment of medical insurance”, providing reference to solve the CAR-T coverage problem in China.

, authors=Shuie LI1, Jinxi DING1, 2, *, Jiaming LI1, 2, Yuqing REN1, 2, Wei LI1, 2, authorsList=Shuie LI, Jinxi DING, Jiaming LI, Yuqing REN, Wei LI, authorCompany=null, correspAuthors=Jinxi DING, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330225316083119100, articleId=1330225315651105786, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=嵌合抗原受体T细胞产品医保准入困境分析, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=

嵌合抗原受体T细胞(chimeric antigen receptor T cell,CAR-T)是一种新型肿瘤免疫治疗药物,临床疗效好,但治疗费用高昂。全球已有多个国家将CAR-T产品纳入医疗保障范围以提高其可支付性,但现阶段CAR-T产品尚未纳入我国基本医疗保险目录。该文通过梳理CAR-T产品全球治疗现状和准入情况,总结中国医保准入CAR-T产品的3个难点,提出“商保独立支付—商保协同支付—医保常规支付”的三阶段解决方案,为解决我国CAR-T产品保障问题提供助力。

, authors=李水娥1, 丁锦希1, 2, *, 李佳明1, 2, 任雨青1, 2, 李伟1, 2, authorsList=李水娥, 丁锦希, 李佳明, 任雨青, 李伟, authorCompany=null, correspAuthors=丁锦希, authorNote=

李水娥,硕士研究生,研究方向:医保准入与医药知识产权研究。

, correspAuthorsNote=
丁锦希,教授,博士生导师,研究方向:医药政策法规、医药市场准入与药物经济学。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=bt9ClBVFjC2wPAjMFZXbeA==, magXml=TkUUZRHWBUSV+c+WqZeFfA==, pdfUrl=null, pdf=bAPrQ/Jv3uKu9MJfo2hIUg==, pdfFileSize=1878467, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=ZZDsARQ+9ln4OsfQXn2ZoA==, mapNumber=null, fund=null)}, authors=[Author(id=1330225317991526403, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225318071218181, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, authorId=1330225317991526403, language=EN, stringName=Shuie LI, firstName=Shuie, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225318150909958, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, authorId=1330225317991526403, language=CN, stringName=李水娥, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国药科大学国际医药商学院,江苏 南京 211198, bio={"content":"

李水娥,硕士研究生,研究方向:医保准入与医药知识产权研究。

"}, bioImg=null, bioContent=

李水娥,硕士研究生,研究方向:医保准入与医药知识产权研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225316259279869, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, xref=1., ext=[AuthorCompanyExt(id=1330225316267668478, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225316259279869, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225316271862783, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225316259279869, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)])]), Author(id=1330225318226407433, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225318318682124, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, authorId=1330225318226407433, language=EN, stringName=Jinxi DING, firstName=Jinxi, middleName=null, lastName=DING, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225318389985295, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, authorId=1330225318226407433, language=CN, stringName=丁锦希, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.中国药科大学国际医药商学院,江苏 南京 211198
2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225316259279869, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, xref=1., ext=[AuthorCompanyExt(id=1330225316267668478, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225316259279869, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225316271862783, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225316259279869, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)]), AuthorCompany(id=1330225317916029952, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, xref=2., ext=[AuthorCompanyExt(id=1330225317924417536, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225317916029952, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225317932806145, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225317916029952, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198)])]), Author(id=1330225318444511249, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225318524203028, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, authorId=1330225318444511249, language=EN, stringName=Jiaming LI, firstName=Jiaming, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225318587117589, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, authorId=1330225318444511249, language=CN, stringName=李佳明, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国药科大学国际医药商学院,江苏 南京 211198
2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225316259279869, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, xref=1., ext=[AuthorCompanyExt(id=1330225316267668478, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225316259279869, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225316271862783, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225316259279869, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)]), AuthorCompany(id=1330225317916029952, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, xref=2., ext=[AuthorCompanyExt(id=1330225317924417536, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225317916029952, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225317932806145, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225317916029952, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198)])]), Author(id=1330225318645837847, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225318742306842, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, authorId=1330225318645837847, language=EN, stringName=Yuqing REN, firstName=Yuqing, middleName=null, lastName=REN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225318851358747, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, authorId=1330225318645837847, language=CN, stringName=任雨青, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国药科大学国际医药商学院,江苏 南京 211198
2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225316259279869, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, xref=1., ext=[AuthorCompanyExt(id=1330225316267668478, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225316259279869, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225316271862783, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225316259279869, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)]), AuthorCompany(id=1330225317916029952, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, xref=2., ext=[AuthorCompanyExt(id=1330225317924417536, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225317916029952, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225317932806145, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225317916029952, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198)])]), Author(id=1330225318910079005, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225318993965088, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, authorId=1330225318910079005, language=EN, stringName=Wei LI, firstName=Wei, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225319065268257, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, authorId=1330225318910079005, language=CN, stringName=李伟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国药科大学国际医药商学院,江苏 南京 211198
2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225316259279869, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, xref=1., ext=[AuthorCompanyExt(id=1330225316267668478, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225316259279869, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225316271862783, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225316259279869, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)]), AuthorCompany(id=1330225317916029952, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, xref=2., ext=[AuthorCompanyExt(id=1330225317924417536, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225317916029952, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225317932806145, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225317916029952, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198)])])], keywords=[Keyword(id=1330225319153348642, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, language=EN, orderNo=1, keyword=chimeric antigen receptor T cell (CAR-T)), Keyword(id=1330225319270789155, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, language=EN, orderNo=2, keyword=treatment progression), Keyword(id=1330225319350480932, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, language=EN, orderNo=3, keyword=medical insurance access dilemma), Keyword(id=1330225319417589797, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, language=CN, orderNo=1, keyword=嵌合抗原受体T细胞(CAR-T)), Keyword(id=1330225319480504358, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, language=CN, orderNo=2, keyword=治疗进展), Keyword(id=1330225319547613223, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, language=CN, orderNo=3, keyword=医疗保障准入困境)], refs=[Reference(id=1330225319727968297, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Jackson HJ, Rafiq S, Brentjens RJ. Driving CAR T-cells forward[J]. Nat Rev Clin Oncol, 2016, 13(6): 370-383., articleTitle=null, refAbstract=null), Reference(id=1330225319786688554, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=王芳旭, 陶立波. 嵌合抗原受体T细胞免疫疗法的医保准入路径分析[J]. 中国卫生经济, 2020, 39(9): 22-25., articleTitle=null, refAbstract=null), Reference(id=1330225319845408811, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=赵丽平, 潘静, 冯晓明. CAR-T细胞治疗血液肿瘤的临床进展[J]. 中国细胞生物学学报, 2022, 44(1): 214-222., articleTitle=null, refAbstract=null), Reference(id=1330225319912517676, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Maude SL, Frey N, Shaw PA, et al. Chimeric antigen receptor T cells for sustained remissions in leukemia[J]. N Engl J Med, 2014, 371(16): 1507-1517., articleTitle=null, refAbstract=null), Reference(id=1330225319975432237, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=National Comprehensive Cancer Network, Guidelines for Acute Lymphoblastic Leukemia (2021)[EB/OL]. [2022-02-25]. https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients., articleTitle=null, refAbstract=null), Reference(id=1330225320038346798, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=21世纪经济报道. 第二款CAR-T产品获批上市: 中国迎跨时代大品类, 在研产品超30款[EB/OL]. [2022-02-25]. https://m.21jingji.com/article/20210903/herald/4de9bc12e80903e70555ee1d8cbf036f_ths.html., articleTitle=null, refAbstract=null), Reference(id=1330225320105455663, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Cao X, Li W, Yu Y, et al. China enters CAR-T cell therapy era[J]. Innovation (N Y), 2021, 3(1): 100197., articleTitle=null, refAbstract=null), Reference(id=1330225320172564528, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=中国抗癌协会淋巴瘤专业委员会, 中国医师协会肿瘤医师分会, 中国医疗保健国际交流促进会肿瘤内科分会. 中国淋巴瘤治疗指南(2021年版)[J]. 中华肿瘤杂志, 2021, 43(7): 707-735., articleTitle=null, refAbstract=null), Reference(id=1330225320239673393, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Carlson JJ, Sullivan SD, Garrison LP, et al. Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers[J]. Health Policy, 2010, 96(3): 179-190., articleTitle=null, refAbstract=null), Reference(id=1330225320327753778, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=李伟, 郑晓玲, 丁锦希, 等. 创新药物疗效风险分担协议的应用经验及启示[J]. 中国新药与临床杂志, 2021, 40(11): 750-755., articleTitle=null, refAbstract=null), Reference(id=1330225320386474035, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=李伟, 覃胡莉, 丁锦希, 等. CAR-T产品医保准入风险分担协议的国际经验及启示[J]. 中国药房, 2021, 32(24): 2957-2962., articleTitle=null, refAbstract=null), Reference(id=1330225320457777204, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=丁锦希, 李伟. “守正创新, 为人民健康谋福祉”谈2021年国家医保目录调整工作的三大亮点[J]. 世界临床药物, 2022, 43(1): 1-4., articleTitle=null, refAbstract=null), Reference(id=1330225320520691765, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=国家统计局. 2021年居民收入和消费支出情况[EB/OL]. [2022-02-23]. http://www.stats.gov.cn/xxgk/sjfb/zxfb2020/202201/t20220117_1826442.html., articleTitle=null, refAbstract=null), Reference(id=1330225320583606326, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhu F, Wei G, Zhang M, et al. Factors associated with costs in chimeric antigen receptor T-cell therapy for patients with relapsed/refractory B-cell malignancies[J]. Cell Transplant, 2020, 29: 1-10., articleTitle=null, refAbstract=null), Reference(id=1330225320663298103, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=GILEAD. Yescarta® ZUMA-12 study demonstrates 78% complete response rate as part of first-line treatment in newly diagnosed high-risk large B-cell lymphoma[EB/OL]. [2022-02-25]. https://www.gilead.com/news-and-press/press-room/press-releases/2021/12/yescarta-zuma12-study-demonstrates-78-complete-response-rate-as-part-of-firstline-treatment-in-newly-diagnosed-highrisk-large-bcell-lymphoma., articleTitle=null, refAbstract=null), Reference(id=1330225320738795576, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Evans SR. Clinical trial structures[J]. J Exp Stroke Transl Med, 2010, 3(1): 8-18., articleTitle=null, refAbstract=null), Reference(id=1330225322357796921, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Tang H, Foster NR, Grothey A, et al. Comparison of error rates in single-arm versus randomized phase Ⅱ cancer clinical trials[J]. J Clin Oncol, 2010, 28(11): 1936-1941., articleTitle=null, refAbstract=null), Reference(id=1330225322429100090, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=ISPOR. 欧洲、美国和加拿大癌症嵌合抗原受体(CAR-T)细胞疗法的健康技术评估[EB/OL]. [2022-02-25]. https://www.ispor.org/heor-resources/presentations-database/presentation/euro2020-3282/106966., articleTitle=null, refAbstract=null), Reference(id=1330225322496208955, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=中共中央国务院. 关于深化医疗保障制度改革的意见[EB/OL]. [2022-02-25]. http://www.gov.cn/zhengce/2020-03/05/content_5487407.htm., articleTitle=null, refAbstract=null), Reference(id=1330225322571706428, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=苏州本地宝. 苏州苏惠保保险内容2022[EB/OL]. [2022-02-25]. http://suzhou.bendibao.com/live/20211013/95025.shtm., articleTitle=null, refAbstract=null), Reference(id=1330225322663981117, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=丁锦希, 李佳明, 任雨青. 多层次保障框架下的高值创新药物医保准入新思路[J]. 中国医疗保险, 2021, 2: 26-30., articleTitle=null, refAbstract=null)], funds=[Fund(id=1330225319644082216, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, awardId=CPU2018GY4, language=CN, fundingSource=中国药科大学“双一流”学科创新团队建设项目(CPU2018GY4), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1330225316259279869, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, xref=1., ext=[AuthorCompanyExt(id=1330225316267668478, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225316259279869, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225316271862783, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225316259279869, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)]), AuthorCompany(id=1330225317916029952, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, xref=2., ext=[AuthorCompanyExt(id=1330225317924417536, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225317916029952, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225317932806145, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225317916029952, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.04.002, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.04.002, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2022.04.002, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2022.04.002, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1649520000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
嵌合抗原受体T细胞产品医保准入困境分析
李水娥 1 , 丁锦希 1, 2, * , 李佳明 1, 2 , 任雨青 1, 2 , 李伟 1, 2
世界临床药物 | 医药专论 2022,43(4): 352-358
收起
收藏切换
世界临床药物 |医药专论 2022 , 43 (4) : 352 -358
嵌合抗原受体T细胞产品医保准入困境分析
全屏
[Author(id=1330225317991526403, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225318071218181, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, authorId=1330225317991526403, language=EN, stringName=Shuie LI, firstName=Shuie, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225318150909958, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, authorId=1330225317991526403, language=CN, stringName=李水娥, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国药科大学国际医药商学院,江苏 南京 211198, bio={"content":"

李水娥,硕士研究生,研究方向:医保准入与医药知识产权研究。

"}, bioImg=null, bioContent=

李水娥,硕士研究生,研究方向:医保准入与医药知识产权研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225316259279869, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, xref=1., ext=[AuthorCompanyExt(id=1330225316267668478, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225316259279869, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225316271862783, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225316259279869, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)])]), Author(id=1330225318226407433, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225318318682124, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, authorId=1330225318226407433, language=EN, stringName=Jinxi DING, firstName=Jinxi, middleName=null, lastName=DING, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225318389985295, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, authorId=1330225318226407433, language=CN, stringName=丁锦希, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.中国药科大学国际医药商学院,江苏 南京 211198
2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225316259279869, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, xref=1., ext=[AuthorCompanyExt(id=1330225316267668478, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225316259279869, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225316271862783, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225316259279869, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)]), AuthorCompany(id=1330225317916029952, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, xref=2., ext=[AuthorCompanyExt(id=1330225317924417536, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225317916029952, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225317932806145, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225317916029952, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198)])]), Author(id=1330225318444511249, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225318524203028, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, authorId=1330225318444511249, language=EN, stringName=Jiaming LI, firstName=Jiaming, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225318587117589, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, authorId=1330225318444511249, language=CN, stringName=李佳明, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国药科大学国际医药商学院,江苏 南京 211198
2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225316259279869, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, xref=1., ext=[AuthorCompanyExt(id=1330225316267668478, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225316259279869, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225316271862783, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225316259279869, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)]), AuthorCompany(id=1330225317916029952, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, xref=2., ext=[AuthorCompanyExt(id=1330225317924417536, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225317916029952, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225317932806145, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225317916029952, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198)])]), Author(id=1330225318645837847, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225318742306842, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, authorId=1330225318645837847, language=EN, stringName=Yuqing REN, firstName=Yuqing, middleName=null, lastName=REN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225318851358747, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, authorId=1330225318645837847, language=CN, stringName=任雨青, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国药科大学国际医药商学院,江苏 南京 211198
2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225316259279869, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, xref=1., ext=[AuthorCompanyExt(id=1330225316267668478, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225316259279869, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225316271862783, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225316259279869, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)]), AuthorCompany(id=1330225317916029952, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, xref=2., ext=[AuthorCompanyExt(id=1330225317924417536, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225317916029952, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225317932806145, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225317916029952, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198)])]), Author(id=1330225318910079005, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225318993965088, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, authorId=1330225318910079005, language=EN, stringName=Wei LI, firstName=Wei, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225319065268257, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, authorId=1330225318910079005, language=CN, stringName=李伟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国药科大学国际医药商学院,江苏 南京 211198
2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225316259279869, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, xref=1., ext=[AuthorCompanyExt(id=1330225316267668478, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225316259279869, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225316271862783, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225316259279869, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)]), AuthorCompany(id=1330225317916029952, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, xref=2., ext=[AuthorCompanyExt(id=1330225317924417536, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225317916029952, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225317932806145, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225315651105786, companyId=1330225317916029952, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198)])])]
李水娥1, 丁锦希1, 2, *, 李佳明1, 2, 任雨青1, 2, 李伟1, 2
作者信息
  • 1.中国药科大学国际医药商学院,江苏 南京 211198
  • 2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198
通讯作者:
丁锦希,教授,博士生导师,研究方向:医药政策法规、医药市场准入与药物经济学。
作者简介:

李水娥,硕士研究生,研究方向:医保准入与医药知识产权研究。

Analysis on the dilemma of medical insurance access for chimeric antigen receptor T cell products
Shuie LI1, Jinxi DING1, 2, *, Jiaming LI1, 2, Yuqing REN1, 2, Wei LI1, 2
Affiliations
  • 1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
  • 2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
出版时间: 2022-04-10 doi: 10.13683/j.wph.2022.04.002
文章导航
收藏切换

嵌合抗原受体T细胞(chimeric antigen receptor T cell,CAR-T)是一种新型肿瘤免疫治疗药物,临床疗效好,但治疗费用高昂。全球已有多个国家将CAR-T产品纳入医疗保障范围以提高其可支付性,但现阶段CAR-T产品尚未纳入我国基本医疗保险目录。该文通过梳理CAR-T产品全球治疗现状和准入情况,总结中国医保准入CAR-T产品的3个难点,提出“商保独立支付—商保协同支付—医保常规支付”的三阶段解决方案,为解决我国CAR-T产品保障问题提供助力。

嵌合抗原受体T细胞(CAR-T)  /  治疗进展  /  医疗保障准入困境

As a novel cancer immunotherapy, chimeric antigen receptor T cell (CAR-T) therapy has good clinical efficacy but high treatment cost. Many foreign countries have included CAR-T in the medical insurance coverage to improve its affordability, however, CAR-T has not been included in National Reimbursement Drug List (NRDL) in China. By sorting the global CAR-T treatment status and medical insurance access situation, the paper summarized three difficulties for CAR-T access to NRDL, and proposed a three-stage solution of “independent payment of commercial health insurance-cooperative payment of commercial health insurance-regular payment of medical insurance”, providing reference to solve the CAR-T coverage problem in China.

chimeric antigen receptor T cell (CAR-T)  /  treatment progression  /  medical insurance access dilemma
李水娥, 丁锦希, 李佳明, 任雨青, 李伟. 嵌合抗原受体T细胞产品医保准入困境分析. 世界临床药物, 2022 , 43 (4) : 352 -358 . DOI: 10.13683/j.wph.2022.04.002
Shuie LI, Jinxi DING, Jiaming LI, Yuqing REN, Wei LI. Analysis on the dilemma of medical insurance access for chimeric antigen receptor T cell products[J]. World Clinical Drug, 2022 , 43 (4) : 352 -358 . DOI: 10.13683/j.wph.2022.04.002
  • 中国药科大学“双一流”学科创新团队建设项目(CPU2018GY4)
参考文献 引证文献
排序方式:
[1]
Jackson HJ, Rafiq S, Brentjens RJ. Driving CAR T-cells forward[J]. Nat Rev Clin Oncol, 2016, 13(6): 370-383.
[2]
王芳旭, 陶立波. 嵌合抗原受体T细胞免疫疗法的医保准入路径分析[J]. 中国卫生经济, 2020, 39(9): 22-25.
[3]
赵丽平, 潘静, 冯晓明. CAR-T细胞治疗血液肿瘤的临床进展[J]. 中国细胞生物学学报, 2022, 44(1): 214-222.
[4]
Maude SL, Frey N, Shaw PA, et al. Chimeric antigen receptor T cells for sustained remissions in leukemia[J]. N Engl J Med, 2014, 371(16): 1507-1517.
[5]
National Comprehensive Cancer Network, Guidelines for Acute Lymphoblastic Leukemia (2021)[EB/OL]. [2022-02-25]. https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients.
[6]
21世纪经济报道. 第二款CAR-T产品获批上市: 中国迎跨时代大品类, 在研产品超30款[EB/OL]. [2022-02-25]. https://m.21jingji.com/article/20210903/herald/4de9bc12e80903e70555ee1d8cbf036f_ths.html.
[7]
Cao X, Li W, Yu Y, et al. China enters CAR-T cell therapy era[J]. Innovation (N Y), 2021, 3(1): 100197.
[8]
中国抗癌协会淋巴瘤专业委员会, 中国医师协会肿瘤医师分会, 中国医疗保健国际交流促进会肿瘤内科分会. 中国淋巴瘤治疗指南(2021年版)[J]. 中华肿瘤杂志, 2021, 43(7): 707-735.
[9]
Carlson JJ, Sullivan SD, Garrison LP, et al. Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers[J]. Health Policy, 2010, 96(3): 179-190.
[10]
李伟, 郑晓玲, 丁锦希, 等. 创新药物疗效风险分担协议的应用经验及启示[J]. 中国新药与临床杂志, 2021, 40(11): 750-755.
[11]
李伟, 覃胡莉, 丁锦希, 等. CAR-T产品医保准入风险分担协议的国际经验及启示[J]. 中国药房, 2021, 32(24): 2957-2962.
[12]
丁锦希, 李伟. “守正创新, 为人民健康谋福祉”谈2021年国家医保目录调整工作的三大亮点[J]. 世界临床药物, 2022, 43(1): 1-4.
[13]
国家统计局. 2021年居民收入和消费支出情况[EB/OL]. [2022-02-23]. http://www.stats.gov.cn/xxgk/sjfb/zxfb2020/202201/t20220117_1826442.html.
[14]
Zhu F, Wei G, Zhang M, et al. Factors associated with costs in chimeric antigen receptor T-cell therapy for patients with relapsed/refractory B-cell malignancies[J]. Cell Transplant, 2020, 29: 1-10.
[15]
GILEAD. Yescarta® ZUMA-12 study demonstrates 78% complete response rate as part of first-line treatment in newly diagnosed high-risk large B-cell lymphoma[EB/OL]. [2022-02-25]. https://www.gilead.com/news-and-press/press-room/press-releases/2021/12/yescarta-zuma12-study-demonstrates-78-complete-response-rate-as-part-of-firstline-treatment-in-newly-diagnosed-highrisk-large-bcell-lymphoma.
[16]
Evans SR. Clinical trial structures[J]. J Exp Stroke Transl Med, 2010, 3(1): 8-18.
[17]
Tang H, Foster NR, Grothey A, et al. Comparison of error rates in single-arm versus randomized phase Ⅱ cancer clinical trials[J]. J Clin Oncol, 2010, 28(11): 1936-1941.
[18]
ISPOR. 欧洲、美国和加拿大癌症嵌合抗原受体(CAR-T)细胞疗法的健康技术评估[EB/OL]. [2022-02-25]. https://www.ispor.org/heor-resources/presentations-database/presentation/euro2020-3282/106966.
[19]
中共中央国务院. 关于深化医疗保障制度改革的意见[EB/OL]. [2022-02-25]. http://www.gov.cn/zhengce/2020-03/05/content_5487407.htm.
[20]
苏州本地宝. 苏州苏惠保保险内容2022[EB/OL]. [2022-02-25]. http://suzhou.bendibao.com/live/20211013/95025.shtm.
[21]
丁锦希, 李佳明, 任雨青. 多层次保障框架下的高值创新药物医保准入新思路[J]. 中国医疗保险, 2021, 2: 26-30.
2022年第43卷第4期
17
5
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2022.04.002
  • 接收时间:2022-01-25
  • 首发时间:2026-11-19
  • 出版时间:2022-04-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2022-01-25
基金
中国药科大学“双一流”学科创新团队建设项目(CPU2018GY4)
作者信息
    1.中国药科大学国际医药商学院,江苏 南京 211198
    2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198

通讯作者:

丁锦希,教授,博士生导师,研究方向:医药政策法规、医药市场准入与药物经济学。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.04.002
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏